1. Home
  2. Labeler Index
  3. Northstar Rx Llc
  4. 16714-137
  5. Product Images: Paclitaxel

Product Images Paclitaxel

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Paclitaxel NDC 16714-137 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

300mg-carton - carton label

300mg-carton - carton label

This is a description of a medication called Paclitaxel Injection, USP. It is a cytotoxic agent that requires dilution prior to intravenous infusion. The medication comes in a multiple dose vial of 50mL and contains 300mg/50mL (6mg/mL) of paclitaxel. The medication is manufactured for Northstar Rx LLC and by MSN Laboratories Private Limited in India. The packaging cautions that gloves should be worn when handling the containers and the medication should be protected from light. The usual dosage information is included in the insert, along with detailed directions for use and precautions. The NDC number for this medication is available.*

fig-1 - figure 1

fig-1 - figure 1

fig-2 - figure 2

fig-2 - figure 2

fig-3 - figure 3

fig-3 - figure 3

fig-4 - figure 4

fig-4 - figure 4

fig-5 - figure 5

fig-5 - figure 5

The text seems to be describing the "Proportion Disease Free" for the "Humber ot sk" in two different years, 2006 and 202%. However, this information is not complete as it lacks the context or more details. Therefore, it's difficult to determine what the values represent or how they were obtained.*

fig-6 - figure 6

fig-6 - figure 6

This text appears to be a graphical representation of disease-free proportions over a period of four years. The X-axis represents the four years, and the y-axis represents the proportion of individuals free of disease. Data is also presented in a table format, with Risk number and proportion of disease-free individuals indicated for each year.*

fig-7 - figure 7

fig-7 - figure 7

This appears to be information from a medical study or clinical trial. The text provides data on the proportion of individuals who are disease-free over a period of four years, as well as the number of events (likely cases of disease). The sample size is 96,963 and the hazard ratio (HR) is 0.83 with a 95% confidence interval between 0.67 and 1.01. The text also shows the number of individuals at risk over time.*

fig-8 - figure 8

fig-8 - figure 8

This is a medical report presenting data on a proportion of disease-free patients using AC+T treatment. It includes the number of events, Hazard Ratio (HR), confidence interval, and the number of patients at risk over 3 years. The text is not clear enough to provide context or additional information on the study or results.*

structure - structure

structure - structure

300MG-VIAL - vial label

300MG-VIAL - vial label

Paclitaxel Injection, USP is a cytotoxic agent used for intravenous infusion. Each mL of the solution contains 6 mg of paclitaxel, USP, along with semisynthetic polyoxyl 35 castor oil, nf, and dehydrated alcohol, USP. The usual dosage and dilution requirements can be found in the product insert. The solution comes in a 50 mL multiple dose vial and should be stored between 20°C to 25°C, protected from light. The product is manufactured by MSN Laboratories Private Limited in Telangana, India, and distributed by Northstar Rx LLC in Memphis, TN. Gloves should be worn at all times when handling containers. This text also includes the product's NDC and manufacturing date.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.